• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. GlaxoSmithKline Start Second Phase Study of Antibody For Inflammatory Osteoarthritis

    GlaxoSmithKline Start Second Phase Study of Antibody For Inflammatory Osteoarthritis

  2. Endometriosis Pipeline Review, H1 2016 - Review of 21 Companies & Drug Profiles - Research and Markets

    Endometriosis Pipeline Review, H1 2016 - Review of 21 Companies & Drug Profiles - Research and Markets

  3. Valeant to Make Sweeping Board Changes -- WSJ

    Valeant to Make Sweeping Board Changes -- WSJ

  4. Valeant to Make Sweeping Changes to Board

    Valeant to Make Sweeping Changes to Board

  5. Valeant Pharmaceuticals to Make Sweeping Changes to Board

    Valeant Pharmaceuticals to Make Sweeping Changes to Board

  6. Global Human Vaccine Market Growth 11.69% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: GlaxoSmithKline , Merck, Pfizer - Research and Markets

    Global Human Vaccine Market Growth 11.69% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: GlaxoSmithKline , Merck, Pfizer - Research and Markets

  7. Novartis Feels the Effect Of Drop in Gleevec Sales -- WSJ

    Novartis Feels the Effect Of Drop in Gleevec Sales -- WSJ

  8. Metastatic Adenocarcinoma of The Pancreas Pipeline Review, H1 2016 - Research and Markets

    Metastatic Adenocarcinoma of The Pancreas Pipeline Review, H1 2016 - Research and Markets

  9. Novartis Earnings Fall on Slide in Cancer-Drug Sales

    Novartis Earnings Fall on Slide in Cancer-Drug Sales

  10. Novartis Earnings Fall on Slide in Cancer-Drug Sales

    Novartis Earnings Fall on Slide in Cancer-Drug Sales

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.